BioConnects New England (BCNE) Partners with Thermo Fisher, Mass Life Sciences Center and Northeastern University to Host Booth at JA Inspire

BioConnects New England

BioConnects New England (BCNE) partnered with Thermo Fisher Scientific and the Massachusetts Life Sciences Center (MLSC) to introduce 8th-grade students to career opportunities in the life sciences at the Junior Achievement of Greater Boston’s JA Inspire expo held at Boston’s Hynes Convention Center in December.

JA Inspire

JA Inspire is a powerful event designed to share career opportunities with 1,200 middle school students from cities such as Boston, Chelsea, Lawrence, Lowell, Lynn, and Quincy. “It was great to join forces with two of our closest partners in BCNE and ThermoFisher Scientific at JA Inspire to highlight the MLSC internship programs and other resources for students interested in life sciences careers,” said Ryan Mudawar, VP of Education and Workforce Programs at the MLSC. “It was truly energizing to engage with hundreds of local middle and high school students and help them understand the great potential and opportunity that the life sciences industry can offer them right here in Massachusetts.”

Volunteering with JA Inspire

“Volunteering with JA Inspire was such an impactful experience that allowed us to introduce the intersection between science and business to young students,” Jordyn Blake, biosciences account manager at ThermoFisher’s Life Sciences Solutions Group in Boston, said. “They were so engaged in learning about career pathways outside of the traditional STEM careers.  I am glad we were able to play a part in inspiring the next generation of innovators and scientists by sharing our journeys.”

“Northeastern seeks to bring the best of its resources and reach to events like JA Inspire. Our research government affairs and BioConnects New England teams collaborate regularly on these opportunities to drive tangible impact locally,” said Dana DeBari, Director of Government Relations & Strategic Projects at Northeastern. “JA Inspire is a one-of-a-kind event where we can interact with young learners and really get them thinking about careers in biomanufacturing and the life sciences in companies, labs, and academic and research institutions across New England.”

Future of Biotech

BCNE believes that the future of biotech relies heavily on creating access, education, and connection to the industry for young people. Junior Achievement Boston has built a brilliant opportunity with its annual JA Inspire Event.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”